An Overview of New Treatments for Dry AMD
January 2, 2010
In the November 2009 issue of Retinal Physician, Dr. Philip Rosenfeld and medical student John Legarreta wrote an excellent overview of the current drugs in development or in clinical trials for the treatment of dry AMD.
With about 80% to 90% of newly diagnosed AMD cases being of the dry variety, and with no effective treatment currently in use, it is important to track the developmental work underway in this area. This review was reproduced with the permission of the magazines publishers on my online Journal.
Please follow this link for the complete writeup.
Comments
Jump down to form below to submit your own comments
One Response to “An Overview of New Treatments for Dry AMD”
There is hope for dry AMD sufferers
Checkout the website for TOZAL http://www.tozalvitamins.com/
Sign up for the webinar and use the link to the TOZA clinical study.
Gillian Wilson
